A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination

We present a 65-year-old woman who developed sudden and severe vision loss in her left eye one day after the administration of the second dose of coronavirus disease-19 vaccine. The best corrected visual acuity in this eye was 1/10. Diffuse paracentral acute middle maculopathy was detected on spectr...

Descripción completa

Detalles Bibliográficos
Autores principales: Menteş, Jale, Nalçacı, Serhad, Değirmenci, Cumali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286837/
https://www.ncbi.nlm.nih.gov/pubmed/37345327
http://dx.doi.org/10.4274/tjo.galenos.2023.65118
_version_ 1785061830058573824
author Menteş, Jale
Nalçacı, Serhad
Değirmenci, Cumali
author_facet Menteş, Jale
Nalçacı, Serhad
Değirmenci, Cumali
author_sort Menteş, Jale
collection PubMed
description We present a 65-year-old woman who developed sudden and severe vision loss in her left eye one day after the administration of the second dose of coronavirus disease-19 vaccine. The best corrected visual acuity in this eye was 1/10. Diffuse paracentral acute middle maculopathy was detected on spectral domain optical coherence tomography (OCT). OCT angiography images revealed concurrent vascular flow defects consistent with acute macular neuroretinopathy in the deep retinal capillary plexus and choriocapillaris layers. At the end of the six-month follow-up, there was no improvement in visual acuity, and atrophy and thinning developed in all layers of the retina.
format Online
Article
Text
id pubmed-10286837
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-102868372023-06-23 A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination Menteş, Jale Nalçacı, Serhad Değirmenci, Cumali Turk J Ophthalmol Case Report We present a 65-year-old woman who developed sudden and severe vision loss in her left eye one day after the administration of the second dose of coronavirus disease-19 vaccine. The best corrected visual acuity in this eye was 1/10. Diffuse paracentral acute middle maculopathy was detected on spectral domain optical coherence tomography (OCT). OCT angiography images revealed concurrent vascular flow defects consistent with acute macular neuroretinopathy in the deep retinal capillary plexus and choriocapillaris layers. At the end of the six-month follow-up, there was no improvement in visual acuity, and atrophy and thinning developed in all layers of the retina. Galenos Publishing 2023-06 2023-06-21 /pmc/articles/PMC10286837/ /pubmed/37345327 http://dx.doi.org/10.4274/tjo.galenos.2023.65118 Text en © Copyright 2023 by Turkish Ophthalmological Association | Turkish Journal of Ophthalmology, published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Menteş, Jale
Nalçacı, Serhad
Değirmenci, Cumali
A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
title A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
title_full A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
title_fullStr A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
title_full_unstemmed A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
title_short A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
title_sort case of concurrent acute macular neuroretinopathy and paracentral acute middle maculopathy following pfizer-biontech covid-19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286837/
https://www.ncbi.nlm.nih.gov/pubmed/37345327
http://dx.doi.org/10.4274/tjo.galenos.2023.65118
work_keys_str_mv AT mentesjale acaseofconcurrentacutemacularneuroretinopathyandparacentralacutemiddlemaculopathyfollowingpfizerbiontechcovid19vaccination
AT nalcacıserhad acaseofconcurrentacutemacularneuroretinopathyandparacentralacutemiddlemaculopathyfollowingpfizerbiontechcovid19vaccination
AT degirmencicumali acaseofconcurrentacutemacularneuroretinopathyandparacentralacutemiddlemaculopathyfollowingpfizerbiontechcovid19vaccination
AT mentesjale caseofconcurrentacutemacularneuroretinopathyandparacentralacutemiddlemaculopathyfollowingpfizerbiontechcovid19vaccination
AT nalcacıserhad caseofconcurrentacutemacularneuroretinopathyandparacentralacutemiddlemaculopathyfollowingpfizerbiontechcovid19vaccination
AT degirmencicumali caseofconcurrentacutemacularneuroretinopathyandparacentralacutemiddlemaculopathyfollowingpfizerbiontechcovid19vaccination

Ejemplares similares